Dasotraline is a triple reuptake inhibitor that blocks dopamine (DA), norepinephrine (NE), and serotonin [5-hydroxytryptamine (5-HT)] transporters with IC50 values of 4, 6, and 11 nM, respectively, representing a potential new class of antidepressant agents.